A Validated RP-HPLC Method for Simultaneous Estimation of Nebivolol and Hydrochlorothiazide in Tablets
2008

RP-HPLC Method for Estimating Nebivolol and Hydrochlorothiazide

Sample size: 20 publication Evidence: high

Author Information

Author(s): Meyyanathan S. N., Rajan S. Muralidharan S., Birajdar Arunadevi S., Suresh B.

Primary Institution: J. S. S. College of Pharmacy, Ootacamund, India

Hypothesis

The study aims to develop a validated RP-HPLC method for the simultaneous estimation of nebivolol and hydrochlorothiazide in tablets.

Conclusion

The developed RP-HPLC method is accurate, precise, and suitable for quality control of nebivolol and hydrochlorothiazide in combined dosage forms.

Supporting Evidence

  • The method was validated according to ICH guidelines.
  • Recovery studies showed an average recovery of 98.25% for nebivolol and 98.65% for hydrochlorothiazide.
  • The method demonstrated good linearity with R2 values of 0.998 for nebivolol and 0.9995 for hydrochlorothiazide.
  • The limit of detection was found to be 10 ng/ml for nebivolol and 5 ng/ml for hydrochlorothiazide.
  • The method was shown to be rugged and robust across different instruments and conditions.

Takeaway

The researchers created a new way to measure two heart medications in tablets quickly and accurately.

Methodology

A reverse phase high pressure liquid chromatographic method was developed and validated for accuracy, precision, linearity, limit of detection, and limit of quantitation.

Digital Object Identifier (DOI)

10.4103/0250-474X.45420

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication